Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

* * * Section 1 - Chemical Product and Company Identification * * *

Chemical Name: Salicylic Acid
Product Use: For Commercial Use
Synonyms: Benzoic Acid, 2-Hydroxy-; o-Carboxyphenol; 2-Carboxyphenol; 2-Hydroxybenzenecarboxylic Acid; oHydroxybenzoic; 2-Hydroxybenzoic Acid; Phenol-2-Carboxylic Acid; Salonil, SA; SAX; Verrugon
Supplier Information
Chem One Ltd.
Phone: (713) 896-9966
14140 Westfair East Drive
Fax: (713) 896-7540
Houston, Texas 77041-1104
Emergency # (800) 424-9300 or (703) 527-3887
General Comments: FOR COMMERCIAL USE ONLY; NOT TO BE USED AS A PESTICIDE.
NOTE: Emergency telephone numbers are to be used only in the event of chemical emergencies involving a spill, leak, fire,
exposure, or accident involving chemicals. All non-emergency questions should be directed to customer service.

* * * Section 2 - Composition / Information on Ingredients * * *

CAS #
Component
69-72-7
Salicylic Acid
Component Information/Information on Non-Hazardous Components
This product is considered hazardous under 29 CFR 1910.1200 (Hazard Communication).

Percent
100

* * * Section 3 - Hazards Identification * * *

Emergency Overview
Salicylic Acid is a white solid in crystalline or powder form with a slight phenolic odor. May cause irritation to eye, skin, and
respiratory system. Prolonged or concentrated contact may cause burns, by all routes of exposure. As an organic solid, dusts of
Salicylic Acid can form explosive air/dust mixtures. If heated to sublimation temperature (170-300 deg F), ignitable vapors may
be produced. When heated to decomposition, Salicylic Acid may emit toxic fumes of phenol, carbon monoxide and carbon
dioxide.
Hazard Statements
CAUTION! MAY FORM COMBUSTIBLE DUST CONCENTRATIONS IN AIR (DURING PROCESSING). May be
harmful if inhaled, ingested or by skin contact. May cause eye, skin and respiratory irritation or burns. May cause systemic
effects if large areas of skin are contaminated. Avoid breathing dusts or fumes. Avoid contact with eyes, skin and clothing. Keep
container closed. Use only with adequate ventilation. Do not take internally. Wash thoroughly after handling.
Potential Health Effects: Eyes
Exposure to particulates or solution of Salicylic Acid may cause mild to severe irritation of the eyes, depending on the duration of
exposure, with symptoms such as stinging, tearing and redness. Prolonged contact with the eyes may result in corneal injury.
Potential Health Effects: Skin
Salicylic Acid can cause moderate irritation of the skin, especially after prolonged exposures. Contact with skin in the presence of
moisture may result in burns. Contact with damaged skin may cause swelling and scaling of skin. If large areas of the skin are
contaminated with Salicylic Acid, systemic poisoning can occur, with symptoms including tinnitus. Other symptoms of skin
absorption may include those of salicylism described under Ingestion. Rashes may occur in sensitive individuals. Repeated
skin contact may lead to dermatitis (red, cracked skin). The lowest toxic human dose (TDLo) by skin exposure has been reported
as 57-111 mg/kg, with symptoms of tinnitus, increased pulse rate and body temperature increase.
Potential Health Effects: Ingestion
If ingested, Salicylic Acid has a sweetish taste, and acrid aftertaste. Ingestion of Salicylic Acid (especially in large volumes) can
irritate the tissues of the mouth, esophagus, and other tissues of the digestive system. Symptoms of exposure can include
vomiting, diarrhea, nausea, abdominal pain, increased respiration, asthma, drowsiness, and mental disturbances. Mild chronic
salicylate intoxication is termed salicylism. Syndrome includes headache, dizziness, ringing in the ears, difficulty in hearing, dimness
of vision, mental confusion, lassitude, drowsiness, sweating, thirst, hyperventilation, nausea, vomiting, & occasionally diarrhea. A
more severe degree of salicylate intoxication is characterized by more pronounced central nervous system disturbances (including
generalized convulsions and coma), skin eruptions, and marked alterations in acid-base balance. Ingestion exposure may result in
kidney damage, based on animal data.
Potential Health Effects: Inhalation
Breathing dusts or particulates generated by Salicylic Acid can lead to irritation or burns of the nose, throat or respiratory system,
depending on concentration or duration of exposure. Symptoms of initial exposure could include coughing and sneezing.
Symptoms of more concentrated exposure may include headache, dizziness, rapid pulse, tinnitus and those symptoms as described
under Ingestion. Inhalation exposure of 0.9 mg/L has caused salivation and nasal discharge in animals.

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 1 of 9

Revision Date: 06/14/10 2:37 PM SEP

Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

* * * Section 3 - Hazards Identification (Continued) * * *

HMIS Ratings: Health Hazard: 1* Fire Hazard: 1 Physical Hazard: 0
Hazard Scale: 0 = Minimal 1 = Slight 2 = Moderate 3 = Serious 4 = Severe * = Chronic hazard

* * * Section 4 - First Aid Measures * * *

First Aid: Eyes
If product contacts eyes, get immediate medical attention. Immediately rinse affected eye with plenty of water for at least 15
minutes. If symptoms persist after 15 minutes of irrigation, seek medical attention.
First Aid: Skin
Remove all contaminated clothing. For skin contact, wash the exposed area extremely thoroughly with soap and water. Seek
medical attention if irritation persists. Wash all contaminated clothing before reuse.
First Aid: Inhalation
Remove source of contamination or move victim to fresh air. Apply artificial respiration if victim is not breathing. Do not use
mouth-to-mouth method if victim ingested or inhaled the substance; induce artificial respiration with the aid of a pocket mask
equipped with a one-way valve or other proper respiratory medical device. Administer oxygen if breathing is difficult. Get
immediate medical attention.
First Aid: Ingestion
DO NOT INDUCE VOMITING, unless directed by medical personnel. Have victim rinse mouth thoroughly with water, if
conscious. Never give anything by mouth to a victim who is unconscious or having convulsions. Contact a physician or poison
control center immediately.
First Aid: Notes to Physician
Treatment is largely symptomatic. Absorption of Salicylic Acid from the gastrointestinal tract can be reduced by emesis, gastric
lavage, administration of activated charcoal, or combination of these. The patient should be hospitalized and blood should be obtained
for plasma salicylate determinations and acid-base and electrolyte studies. Measures to rid body rapidly of salicylate should be
undertaken immediately. Diuresis with alkalinizing solution appears to be better than alkali alone. If patient presents with acidosis,
correction of low blood pH is essential. Bicarbonate solution should be infused via IV to combat acidosis and if possible, to maintain
alkaline diuresis. Hyperthermia and dehydration are the immediate threats to life, and the initial therapy must be directed to their
correction and to maintenance of adequate renal function. If potassium deficiency occurs it should be treated by adding cation to IV
fluids once it has been determined urine formation is adequate. Plasma transfusion may be beneficial especially if shock syndrome
intervenes. Any attempt to obtund salicylate-induced hyperventilation by giving barbiturate or narcotic is dangerous and may lead to
respiratory acidosis and coma. In severe intoxication, hemodialysis is the most effective measure available Hemodialysis should be
considered in patients with salicylate concentrations above 1000 g/ml, in those with severe acid base disturbances and who are
deteriorating despite therapy, and in those with associated serious disease. For the treatment of allergic responses, epinephrine is the
drug of choice. Hemorrhagic phenomena may necessitate whole-blood transfusion and vitamin K.

* * * Section 5 - Fire Fighting Measures * * *

Flash Point: 157 deg C (314.6 deg F)
Method Used: Closed Cup
Upper Flammable Limit (UEL): Not Determined
Lower Flammable Limit (LEL): 1.1% (@ 200 deg C)
Auto Ignition: 540 deg C (1004 deg F)
Flammability Classification: Combustible
General Fire Hazards
Dusts of this compound can combine with air to form explosive air/dust mixtures. Salicylic Acid will sublime above 170-300 deg F,
forming potentially explosive and toxic vapors of phenol and carbon dioxide. Finely divided dusts from this material can form
explosive mixtures in air. Large dust clouds from product have the potential to ignite explosively. Refer to NFPA 654, Standard for
the Prevention of Fire and Dust Explosions from the Manufacturing, Processing, and Handling of Combustible Particulate Solids,
for comprehensive guidance.
Hazardous Combustion Products
When heated to decomposition, this product may emit toxic fumes of carbon dioxide, carbon monoxide and phenol.
Extinguishing Media
Extinguish fire with water, dry chemical, carbon dioxide, and foam. Fine water spray will effectively reduce fume and irritant
gases. Water or foam may cause frothing if it sinks below the surface of the burning material and turns to steam. However, a water
fog that is gently applied to the surface of the material will cause a frothing which will extinguish the fire.
Fire Fighting Equipment/Instructions
Firefighters should wear full protective clothing including self-contained breathing apparatus.
NFPA Ratings: Health: 1 Fire: 1 Reactivity: 0 Other:
Hazard Scale: 0 = Minimal 1 = Slight 2 = Moderate 3 = Serious 4 = Severe

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 2 of 9

Revision Date: 06/14/10 2:37 PM SEP

Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

* * * Section 6 - Accidental Release Measures * * *

Containment Procedures
Stop the flow of material, if this can be done without risk. Contain the discharged material. If sweeping of a contaminated area is
necessary use a dust suppressant agent, which does not react with product (see Section 10 for incompatibility information).
Clean-Up Procedures
Wear appropriate protective equipment and clothing during clean-up. Shovel the material into waste container. Thoroughly wash
the area after a spill or leak clean-up. Avoid contamination of soil, and prevent spill residue from running to groundwater or
storm drains.
Evacuation Procedures
Evacuate the area promptly and keep upwind of the spilled material. Isolate the spill area to prevent people from entering. Keep
materials that burn away from spilled material. In case of large spills, follow all facility emergency response procedures.
Special Procedures
Remove soiled clothing and launder before reuse. Avoid all skin contact with the spilled material. Have emergency equipment
readily available.

* * * Section 7 - Handling and Storage * * *

Handling Procedures
All employees who handle this material should be trained to handle it safely. Do not breathe dust. Avoid all contact with skin and eyes.
Use this product only with adequate ventilation. Wash thoroughly after handling. Areas in which this compound is used should be
wiped down periodically so that this substance is not allowed to accumulate. Dry powders can build static electricity charges when
subjected to the friction of transfer and mixing operations. Provide adequate precautions, such as electrical grounding and bonding,
or inert atmospheres.
Storage Procedures
Keep container tightly closed when not in use. Store containers in a cool, dry location, away from direct sunlight, sources of intense
heat, or where freezing is possible. Material should be stored in secondary containers or in a diked area, as appropriate. Store
containers away from incompatible chemicals (see Section 10, Stability and Reactivity). Storage areas should be made of fire-resistant
materials. Post warning and NO SMOKING signs in storage and use areas, as appropriate. Refer to NFPA 654, Prevention of Fire
and Dust Explosions from the Manufacturing, Processing and Handling of Combustible Particulate Solids for additional information
on storage. Containers of this material should be separated from oxygen, or other oxidizers, by a minimum distance of 20 ft., or by a
barrier of non-combustible material at least 5 ft. high, having a fire-resistance rating of at least 0.5 hours. Additional information can
be found the OSHA Safety and Health Information Bulletin: Combustible Dust in Industry: Preventing and Mitigating the Effects of
Fire and Explosions. Use only appropriately classified electrical equipment and powered industrial trucks. Use corrosion-resistant
structural materials, lighting, and ventilation systems in the storage area. Floors should be sealed to prevent absorption of this
material. Inspect all incoming containers before storage, to ensure containers are properly labeled and not damaged. Have appropriate
extinguishing equipment in the storage area (i.e., sprinkler system, portable fire extinguishers).
Salicylic Acid collodion should be stored in tight containers at 15-30 deg C. Because the collodion is flammable, it should not be
stored near heat or an open flame. Salicylic Acid plaster should be stored in well-closed containers, preferably at 15-30 deg C. The
Trans-Ver-Sal plaster should be stored at a temperature less than 37.8 deg C.
Empty containers may contain residual particulates; therefore, empty containers should be handled with care. Do not cut, grind, weld,
or drill near this container. Never store food, feed, or drinking water in containers that held this product. Keep this material away
from food, drink and animal feed. Do not store this material in open or unlabeled containers. Limit quantity of material stored.

* * * Section 8 - Exposure Controls / Personal Protection * * *

Exposure Guidelines Use a non-sparking, grounded, explosion-proof ventilation system separate from other exhaust ventilation
systems. Ensure that dust-handling systems (such as exhaust ducts, dust collectors, vessels, and processing equipment) are
designed in a manner to prevent the escape of dust into the work area (i.e., there is no leakage from the equipment).
A: General Product Information
B: Component Exposure Limits (cont next page)

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 3 of 9

Revision Date: 06/14/10 2:37 PM SEP

Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

The exposure limits given are for Particulates Not Otherwise Classified (PNOC).
OSHA: 15 mg/m3 TWA (Total dust)
5 mg/m3 TWA (Respirable fraction)
DFG MAKs 4 mg/m3 TWA (Inhalable fraction)
1.5 mg/m3 TWA (Respirable fraction)
Engineering Controls
Use mechanical ventilation such as dilution and local exhaust. Use a corrosion-resistant ventilation system and exhaust directly to
the outside. Supply ample air replacement. Provide dust collectors with explosion vents.
PERSONAL PROTECTIVE EQUIPMENT
The following information on appropriate Personal Protective Equipment is provided to assist employers in complying with OSHA
regulations found in 29 CFR Subpart I (beginning at 1910.132). Please reference applicable regulations and standards for relevant
details.
Personal Protective Equipment: Eyes/Face
Wear safety glasses with side shields (or goggles) and a face shield, if this material is made into solution. If necessary, refer to U.S.
OSHA 29 CFR 1910.133.

* * * Section 8 - Exposure Controls / Personal Protection (Continued) * * *

PERSONAL PROTECTIVE EQUIPMENT (continued)
Personal Protective Equipment: Skin
Where contact is likely, wear chemical resistant gloves, rubber boots, and coveralls. Butyl rubber, natural rubber, or neoprene
gloves are recommended. Gloves should be tested to determine their suitability for prolonged contact with this material. If
necessary, refer to U.S. OSHA 29 CFR 1910.138.
Personal Protective Equipment: Respiratory
None required where adequate ventilation conditions exist. If airborne concentrations are above the applicable exposure limits,
use NIOSH-approved respiratory protection. If respiratory protection is needed, use only protection authorized in the U.S. Federal
OSHA Standard (29 CFR 1910.134), applicable U.S. State regulations. Oxygen levels below 19.5% are considered IDLH by OSHA.
In such atmospheres, use of a full-facepiece pressure/demand SCBA or a full facepiece, supplied air respirator with auxiliary selfcontained air supply is required under OSHAs Respiratory Protection Standard (1910.134-1998).
Personal Protective Equipment: General
Wash hands thoroughly after handling material. Do not eat, drink or smoke in work areas. Have a safety shower or eye-wash
fountain available. Use good hygiene practices when handling this material including changing and laundering work clothing
after use.

* * * Section 9 - Physical & Chemical Properties * * *

Physical Properties: Additional Information
The data provided in this section are to be used for product safety handling purposes. Please refer to Product Data Sheets, Certificates
of Conformity or Certificates of Analysis for chemical and physical data for determinations of quality and for formulation purposes.
Appearance:
Physical State:
Vapor Pressure:
Boiling Point:
Solubility (H2O):
Decomposition Temperature:
Softening Point:
Sublimation Point:
Saturated Vapor Concentration.:
Octanol/H2O Coefficient:
Molecular Weight:

White solid
Crystalline or Powder
1.0 mm kg @ 114 deg C
Not Applicable
0.22%
76 deg C (169 deg F)
Not available
211 deg C (412 deg F)
Not available
Log P 2.26
138.13

Odor:
pH:
Vapor Density:
Freezing/Melting Point:
Specific Gravity:
Particle Size:
Bulk Density:
Volatility:
Heat of Combustion:
Evaporation Rate:
Chemical Formula:

Slight phenolic odor

2.4 (saturated solution)
4.8 (air = 1)
159 deg C (318 deg F)
1.443 (H2O = 1)
Not determined
Not available
Not Applicable
-9,420 Btu/lb
Not available
C7H6O3

* * * Section 10 - Chemical Stability & Reactivity Information * * *

Chemical Stability
Under normal conditions of temperature and pressure, Salicylic Acid is stable. Salicylic Acid may discolor upon exposure to
light, and will sublime above 211 deg C
Chemical Stability: Conditions to Avoid
Avoid high temperatures, excessive heat and incompatible materials.

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 4 of 9

Revision Date: 06/14/10 2:37 PM SEP

Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

Incompatibility
Avoid strong oxidizing agents, strong bases, iodine, ethyl nitrite, lead acetate, mineral acids, and salts of iron. Concentrated
solutions of Salicylic Acid will corrode most common metals.
Hazardous Decomposition
When heated to decomposition, this product may emit toxic fumes of phenol, carbon monoxide, and carbon dioxide.
Hazardous Polymerization
Will not occur.

* * * Section 11 - Toxicological Information * * *

Acute Toxicity
A: General Product Information
Salicylic Acid is toxic by ingestion, intravenous and intraperitoneal routes. Salicylic Acid is toxic by subcutaneous route and is a
suspect teratogen and mutagen, based on animal data. Salicylic Acid causes human systemic effects by skin contact, specifically
resulting in, central nervous system effects, respiratory and cardiac disturbances and tinnitus.
Acute Toxicity (continued)
A: General Product Information (continued)
Acute: May cause eye, skin, nose, throat and respiratory tract irritation or burns, depending on concentration and duration of
exposure and the presence of moisture. Extensive skin contact may result in systemic poisoning, as described in Section 3,
Hazard Identification.
Chronic: Long term skin overexposure to this product may lead to dermatitis (red, itchy skin) and a condition of salicylism
Standard Draize Test (Skin-Rabbit, adult) 500 mg/24 hours: Mild irritation effects; Standard Draize Test (Eye-Rabbit, adult) 100
mg: Severe irritation effects
B: Component Analysis - LD50/LC50
Salicylic Acid (69-72-7)
LD50 (Oral-Rat) 891 mg/kg; LD50 (Oral-Mouse) 480 mg/kg; LD50 (Oral-Rabbit) 1300 mg/kg; LD50 (Oral-Cat, adult) 400 mg/kg;
LD50 (Intraperitoneal-Rat) 157 mg/kg: Behavioral: somnolence (general depressed activity, tremor; Nutritional and Gross Metabolic:
body temperature decrease; LD50 (Intraperitoneal-Mouse) 300 mg/kg; LD50 (Subcutaneous-Mouse) 520 mg/kg; LD50 (IntravenousMouse) 184 mg/kg; LD50 (Skin-Rat) >2 gm/kg: Liver: other changes; Skin and Appendages: hair; LD50 (Skin-Rabbit) > 10 gm/kg;
LC50 (Inhalation-Rat) > 900 mg/m3/1 hour; LC50 (Inhalation-Mammal-species unspecified) > 300 mg/m3
B: Component Analysis - TDLo/LDLo
LDLo (Oral-Rabbit, adult) 1300 mg/kg; LDLo (Subcutaneous-Rabbit, adult) 6 g/kg; TDLo (Oral-Rat) 350 mg/kg (female 8-14 days
post): Teratogenic effects; TDLo (Oral-Rat) 40 mg/kg: female 20-21 day(s) after conception: Reproductive: Maternal Effects:
parturition; TDLo (Oral-Rat) 1050 mg/kg: female 8-14 day(s) after conception: Reproductive: Maternal Effects: uterus, cervix,
vagina; Fertility: post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants), litter size (e.g. #
fetuses per litter; measured before birth); TDLo (Skin-Woman) 111 mg/kg/10 days-intermittent: Sense Organs and Special Senses
(Ear): change in acuity; Cardiac: pulse rate increase, without fall in BP; Nutritional and Gross Metabolic: body temperature increase;
TDLo (Skin-Man) 57 mg/kg: Sense Organs and Special Senses (Ear): tinnitus
Carcinogenicity
A: General Product Information
No information available.
B: Component Carcinogenicity
None of this product's components are listed by ACGIH, IARC, OSHA, NIOSH, or NTP.
Epidemiology
No information available.
Neurotoxicity
No information available.
Mutagenicity
Mutation in Microorganisms (Saccharomyces cerevisiae) 1 mmol/L/3 hours; Mutation in Microorganisms (Salmonella typhimurium)
100 g/disc; DNA Repair (Bacillus subtilis) 5 mg/disc; DNA Inhibition (Oral-Mouse) 100 mg/kg
Teratogenicity
Effects on Embryo or Fetus: fetotoxicity (except death, e.g., stunted fetus); Specific Developmental Abnormalities: other
developmental; TDLo (Oral-Rat) 1050 mg/kg: female 8-14 day(s) after conception: Reproductive: Specific Developmental
Abnormalities: Central Nervous System, craniofacial (including nose and tongue), musculoskeletal system; TDLo (Oral-Rat) 700
mg/kg: female 8-14 day(s) after conception: Reproductive: Effects on Embryo or Fetus: fetotoxicity (except death, e.g., stunted fetus);
Specific Developmental Abnormalities: musculoskeletal system; TDLo (Oral-Mouse) 1 gm/kg: female 17 day(s) after conception:
Reproductive: Fertility: post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants); Effects on

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 5 of 9

Revision Date: 06/14/10 2:37 PM SEP

Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

Embryo or Fetus: fetotoxicity (except death, e.g., stunted fetus); TDLo (Oral-Mouse) 500 mg/kg: female 9 day(s) after conception:
Reproductive: Specific Developmental Abnormalities: musculoskeletal system; TDLo (Subcutaneous-Rat) 380 mg/kg: female 9
day(s) after conception: Reproductive: Fertility: post-implantation mortality (e.g. dead and/or resorbed implants per total number of
implants)
Other Toxicological Information
Salicylic Acid may cross the placental barrier and may be excreted in breast milk. Interactions with drugs may occur.

* * * Section 12 - Ecological Information * * *

Ecotoxicity
Threshold for Immobilization (Daphnia) 48 hours = 1450 ppm (fresh water); LC50 (Ide, Silver or Golden Orfe) 90,000 g/L; EC50
(Daphnia magna water flea) 14,3000 g/L; EC10 (Haematococcus pluvialis green algae) 16,500 g/L;
Environmental Fate
BCF (Lemna minor Duckweed) 72-96 hours = 10,000 g/L
Terrestrial Fate: With a pKa of 2.97, Salicylic Acid and its conjugate base, the salicylate ion, will exist in extremely acidic soils
in varying proportions that are pH dependent. Above pH 5, virtually all Salicylic Acid will exist as the salicylate ion. Anions
generally do not volatilize or undergo adsorption to the extent of their neutral counterparts. Both the vapor pressure and the
Henry's Law constant indicate that volatilization of Salicylic Acid from soil should not be an important fate process.
Biodegradation is expected to be the dominant removal mechanism from terrestrial environments. A soil grab sample study
showed that Salicylic Acid biodegraded rapidly under differing sets of agricultural practices in Pahokee muck soil. Adsorption
should not compete with biodegradation; calculated Koc values (65 to 404) indicate a high to medium mobility class for
Salicylic Acid in soil. Photochemical data in water suggests that Salicylic Acid may possibly photodegrade and polymerize to
form humic materials in sunlit soil surfaces.
Aquatic Fate: With a pKa of 2.97, Salicylic Acid and its conjugate base, the salicylate ion, will exist in extremely acidic natural
waters in varying proportions that are pH dependent. Above pH 5, virtually all Salicylic Acid will exist as the salicylate ion,
which can not volatilize from water or adsorb to particulate matter to the extent of their neutral counterparts. A calculated
Henry's Law constant of 7.34X10-9 atm-cu m/mole at 25C suggests that volatilization of Salicylic Acid from natural bodies of
water will not be an important fate process. The potential for Salicylic Acid to bioconcentrate in aquatic organisms or partition
from the water column to organic matter contained in sediments and suspended solids is low, based on estimated values of log
BCF (0.92 to 1.49) and Koc (65 to 404). However, salicylic acid has been detected in river and sea sediments.
Atmospheric Fate: Based on a vapor pressure of 8.2X10-5 mm Hg at 25C, Salicylic Acid is expected to exist in both the vapor
and particulate phase in ambient air. For gaseous Salicylic Acid in the atmosphere, vapor phase reactions with photochemically
produced hydroxyl radicals may be important. The reaction rate constant was estimated to be 1.32X10-11 cu cm/molecule-sec at
25C, which corresponds to an atmospheric half-life of about 1.2 days at an atmospheric concentration of 5X10+5 hydroxyl
radicals per cu cm. Limited monitoring data has shown that physical removal from air by wet deposition (rainfall, dissolution in
clouds, etc.) and dry deposition of particulate matter can occur.
Bioconcentration: Based on a water solubility of 2,059 mg/L at 25C and a Log Kow of 2.26, the respective bioconcentration factors
of 0.92 and 1.49 have been calculated for Salicylic Acid using recommended regression-derived equations. These BCF values
indicate the potential for Salicylic Acid to bioconcentrate in aquatic organisms is low.

* * * Section 13 - Disposal Considerations * * *

US EPA Waste Number & Descriptions
A: General Product Information
As shipped, product is not considered a hazardous waste by the EPA. Wastes of this compound must be tested using methods
described in 40 CFR Part 261 to determine if it meets applicable definitions of hazardous wastes.
B: Component Waste Numbers
No EPA Waste Numbers are applicable for wastes of Salicylic Acid.
Disposal Instructions
Dispose of in accordance with all applicable Federal, State or provincial, and local regulations.

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 6 of 9

Revision Date: 06/14/10 2:37 PM SEP

Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

* * * Section 14 - Transportation Information * * *

NOTE: The shipping classification information in this section (Section 14) is meant as a guide to the overall classification of the
product. However, transportation classifications may be subject to change with changes in package size. Consult shipper
requirements under I.M.O., I.C.A.O. (I.A.T.A.) and 49 CFR to assure regulatory compliance.
US DOT Information
Shipping Name: Not Regulated
Hazard Class: Not Classified
UN/NA #: Not Applicable
Packing Group: None
Required Label(s): None
50th Edition International Air Transport Association (IATA):
For Shipments by Air transport: This information applies to air shipments both within the U.S. and for shipments originating in the
U.S., but being shipped to a different country.
UN/NA #: UN 3077
Proper Shipping Name: Environmentally Hazardous Substance, solid, n.o.s. (Salicylic Acid)
Hazard Class: 9 (Miscellaneous Dangerous Goods)
Packing Group: III
Passenger & Cargo Aircraft Packing Instruction: 911
Passenger & Cargo Aircraft Maximum Net Quantity: 400 kg
Limited Quantity Packing Instruction (Passenger & Cargo Aircraft): Y911
Limited Quantity Maximum Net Quantity (Passenger & Cargo Aircraft): 30 kg G
Cargo Aircraft Only Packing Instruction: 911
Cargo Aircraft Only Maximum Net Quantity: 400 kg
Excepted Quantities: E1
Special Provisions: A97, A158
ERG Code: 9L
Limited Quantity Shipments: Shipments for air must be marked with the Proper Shipping Name Environmentally Hazardous
Substance, solid, n.o.s. (Salicylic Acid) and shall be marked with the UN Number (3077) preceded by the letters "UN", placed within
a diamond. The width of the line forming the diamond shall be at least 2 mm; the number shall be at least 6 mm high. The total
weight of each outer packaging cannot exceed 30 kg.
Excepted Quantities: The maximum quantity of this material per inner receptacle is limited to 30 g per receptacle and the aggregate
quantity of this material per completed package does not exceed 1kg. The inner receptacles must be securely packed in an
intermediate packaging with cushioning material to prevent movement in the inner receptacles and packed in a strong outer box with a
gross mass not to exceed 29kg. The completed package must meet a drop test. The requirements are found in 2.7.6.1. The package
must not be opened or otherwise altered until it is no longer in commerce. For air transportation no shipping paper is required. The
package must be legibly marked with the following marking:

NOTE: The * must be replaced by the primary hazard class, or when assigned, the division of each of the hazardous materials contained in the package. The ** must be
replaced by the name of the shipper or consignee if not shown elsewhere on the package. The symbol shall be not less than 100 mm x 100 mm and must be durable and
clearly visible.

International Maritime Organization (I.M.O.) Classification

I.M.O. Classification: Salicylic Acid is not regulated under I.M.O.

* * * Section 15 - Regulatory Information * * *

US Federal Regulations
A: General Product Information
None.
B: Component Analysis

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 7 of 9

Revision Date: 06/14/10 2:37 PM SEP

Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

This material contains one or more of the following chemicals required to be identified under SARA Section 302 (40 CFR 355
Appendix A), SARA Section 313 (40 CFR 372.65) and/or CERCLA (40 CFR 302.4):
Salicylic Acid (1066-33-7)
CERCLA: Final RQ = Not Applicable
SARA 302 (EHS TPQ) There are no specific Threshold Planning Quantities for Salicylic Acid. The default Federal
MSDS submission and inventory requirement filing threshold of 10,000 lbs. (4,540 kg) therefore
applies, per 40 CFR 370.20.
C: Sara 311/312 Tier II Hazard Ratings:
Component
CAS #
Fire
Reactivity
Pressure
Immediate
Chronic
Hazard
Hazard
Hazard
Health Hazard Health Hazard
Salicylic Acid
69-72-7
No
No
No
Yes
Yes
State Regulations
A: General Product Information
Other state regulations may apply.
B: Component Analysis - State
The following components appear on one or more of the following state hazardous substance lists:
Component
CAS #
CA
FL
MA MN NJ
PA
Salicylic Acid
69-72-7
No
No
No
No
Yes
Yes
Other Regulations
A: General Product Information
Not determined.
B: Component Analysis - Inventory
Component
CAS #
TSCA
DSL
EINECS
Salicylic Acid
69-72-7
Yes
Yes
Yes
C: Component Analysis - WHMIS IDL
The following components are identified under the Canadian Hazardous Products Act Ingredient Disclosure List:
Component
CAS #
Minimum Concentration
Salicylic Acid
69-72-7
No disclosure limit.
ANSI Labeling (Z129.1):
CAUTION! MAY FORM COMBUSTIBLE DUST CONCENTRATIONS IN AIR (DURING PROCESSING). MAY
CAUSE RESPIRATORY SYSTEM, SKIN AND EYE IRRITATION OR BURNS. HARMFUL IF INGESTED OR INHALED
OR BY SKIN CONTACT. EXTENSIVE SKIN CONTACT MAY CAUSE SYSTEMIC EFFECTS. Avoid contact with skin,
eyes, or clothing. Do not taste or swallow. Avoid breathing dusts and particulates. Use only with adequate ventilation. Keep away
from heat or flame. Keep container closed and grounded. Prevent dust accumulations to minimize explosion hazard. Wash
thoroughly after handling. Wear gloves, goggles, faceshields, suitable body protection, and NIOSH/MSHA-approved respiratory
protection, as appropriate. FIRST-AID: In case of contact, immediately flush skin or eyes with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. If inhaled, remove to fresh air. If ingested, do not induce vomiting. Get
medical attention. IN CASE OF FIRE: Use water fog, dry chemical, CO2, or alcohol foam. IN CASE OF SPILL: Absorb
spill with inert material. Place residue in suitable container. Consult Material Safety Data Sheet for additional information.

* * * Section 16 - Other Information * * *

Other Information
Chem One Ltd. ("Chem One") shall not be responsible for the use of any information, product, method, or apparatus herein
presented ("Information"), and you must make your own determination as to its suitability and completeness for your own use, for
the protection of the environment, and for health and safety purposes. You assume the entire risk of relying on this Information.
In no event shall Chem One be responsible for damages of any nature whatsoever resulting from the use of this product or
products, or reliance upon this Information. By providing this Information, Chem One neither can nor intends to control the
method or manner by which you use, handle, store, or transport Chem One products. If any materials are mentioned that are not
Chem One products, appropriate industrial hygiene and other safety precautions recommended by their manufacturers should be
observed. Chem One makes no representations or warranties, either express or implied of merchantability, fitness for a particular
purpose or of any other nature regarding this information, and nothing herein waives any of Chem One's conditions of sale. This
information could include technical inaccuracies or typographical errors. Chem One may make improvements and/or changes in
the product (s) and/or the program (s) described in this information at any time. If you have any questions, please contact us at
Tel. 713-896-9966 or E-mail us at Safety@chemone.com.

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 8 of 9

Revision Date: 06/14/10 2:37 PM SEP

Material Safety Data Sheet

Material Name: Salicylic Acid

ID: CL-206

Key/Legend
EPA = Environmental Protection Agency; TSCA = Toxic Substance Control Act; ACGIH = American Conference of
Governmental Industrial Hygienists; IARC = International Agency for Research on Cancer; NIOSH = National Institute for
Occupational Safety and Health; NTP = National Toxicology Program; OSHA = Occupational Safety and Health Administration;
WHMIS = Workplace Hazardous Materials Information System
Contact: Sue Palmer-Koleman, PhD
Contact Phone: (713) 896-9966
Revision Log
08/28/00 3:42 PM SEP Changed company name, Sect 1 and 16, from Corporation to Ltd.
05/31/01 9:31 AM HDF Checked exposure limits; made changes to Sect 9; overall review, add SARA 311/312 Haz Ratings.
08/20/01 2:45 PM CLJ Add Shipments by Air information to Section 14, Changed contact to Sue, non-800 Chemtrec Num.
09/25/03 11:00 AM HDF General review of entire MSDS. Up-graded Section 3 Health Hazard information, HMIS categories.
Up-date of exposure limits in Section 8. Addition of current toxicity data to Section 11. Addition of information on environmental
fate in Section 12. Up-Dated Section 14 Transportation Information.
06/22/05 10:05AM SEP Update IATA Section 14
10/19/07 2:08 PM SEP Update IATA Section 14
10/15/08 9:20 AM DLY Changed Chem One Physical Address, Section 1
06/14/2010 SEP Update IATA and air/dust explosion hazard per OSHA guidelines
This is the end of MSDS # CL-206

____________________________________________________________
Issue Date: 03/26/99 13:23:01 CLW

Page 9 of 9

Revision Date: 06/14/10 2:37 PM SEP